[HTML][HTML] Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
…, M Churchman, AM Meynert, T Rye, C Bartos… - Nature …, 2020 - nature.com
Endometrioid ovarian carcinoma (EnOC) demonstrates substantial clinical and molecular
heterogeneity. Here, we report whole exome sequencing of 112 EnOC cases following …
heterogeneity. Here, we report whole exome sequencing of 112 EnOC cases following …
[HTML][HTML] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
RL Hollis, I Croy, M Churchman, C Bartos, T Rye… - British journal of …, 2022 - nature.com
Background Ovarian carcinosarcoma (OCS) is an uncommon, biphasic and highly aggressive
ovarian cancer type, which has received relatively little research attention. Methods We …
ovarian cancer type, which has received relatively little research attention. Methods We …
Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma
…, RL Hollis, CS Herrington, T Rye, C Bartos… - Clinical Cancer …, 2021 - AACR
Purpose: The abundance and effects of structural variation at BRCA1/2 in tumors are not well
understood. In particular, the impact of these events on homologous recombination repair …
understood. In particular, the impact of these events on homologous recombination repair …
Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data
…, K Herbert, M Churchman, C Bartos… - … Journal of Obstetrics …, 2020 - Wiley Online Library
Objective Investigate the clinical landscape of ovarian carcinoma (OC) over time. Design
Register‐based prospectively collected data. Setting South East Scotland. Sample A total of …
Register‐based prospectively collected data. Setting South East Scotland. Sample A total of …
[HTML][HTML] A simple and robust real-time qPCR method for the detection of PIK3CA mutations
PIK3CA mutations are seemingly the most common driver mutations in breast cancer with
H1047R and E545K being the most common of these, accounting together for around 60% of …
H1047R and E545K being the most common of these, accounting together for around 60% of …
[HTML][HTML] Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma
…, K van de Vijver, F Dijk, AM Meynert, C Bartos… - Scientific reports, 2023 - nature.com
Low grade serous ovarian carcinoma (LGSOC) demonstrates unique clinical and molecular
features compared to other ovarian cancer types. The relationship between common …
features compared to other ovarian cancer types. The relationship between common …
Multiomic characterization of high-grade serous ovarian carcinoma enables high-resolution patient stratification
…, I Croy, WG McCluggage, ARW Williams, C Bartos… - Clinical Cancer …, 2022 - AACR
Purpose: High-grade serous ovarian carcinoma (HGSOC) is the most common ovarian
cancer type; most patients experience disease recurrence that accumulates chemoresistance, …
cancer type; most patients experience disease recurrence that accumulates chemoresistance, …
[HTML][HTML] PIK3CA mutation enrichment and quantitation from blood and tissue
…, I Garcia-Murillas, M Beaney, NC Turner, C Bartos… - Scientific reports, 2020 - nature.com
PIK3CA is one of the two most frequently mutated genes in breast cancers, occurring in 30–40%
of cases. Four frequent ‘hotspot’ PIK3CA mutations (E542K, E545K, H1047R and …
of cases. Four frequent ‘hotspot’ PIK3CA mutations (E542K, E545K, H1047R and …
[HTML][HTML] Clinicopathological determinants of recurrence risk and survival in mucinous ovarian carcinoma
RL Hollis, LJ Stillie, S Hopkins, C Bartos, M Churchman… - Cancers, 2021 - mdpi.com
Simple Summary Mucinous ovarian carcinoma (MOC) is a unique type of ovarian cancer.
While many MOC patients have excellent survival, patients who experience recurrence have …
While many MOC patients have excellent survival, patients who experience recurrence have …
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome
…, K van de Vijver, F Dijk, AM Meynert, C Bartos… - Gynecologic …, 2023 - Elsevier
Objectives Low-grade serous ovarian carcinoma (LGSOC) is a distinct, rare, ovarian cancer
type characterised by younger patient age and intrinsic chemoresistance. Understanding the …
type characterised by younger patient age and intrinsic chemoresistance. Understanding the …